Advances in neurosteroids: role in clinical practice

References

• Wang MD, Wahlström G, Bäckström T. The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion. J Steroid Biochem Mol Biol 1997;62:299–306
   PubMed Web of Science ®Google Scholar
• Baulieu EE. Neurosteroids: a new function in the brain. Biol Cell 1991;71:3–10
   PubMed Web of Science ®Google Scholar
• Baulieu EE. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 1997;52:1–32
   PubMedGoogle Scholar
• Pluchino N, Luisi M, Lenzi E, et al. Progesterone and progestins: Effects on brain, allopregnanolone and β-endorphin. J Steroid Biochem Mol Biol 2006;102:205–13
   PubMed Web of Science ®Google Scholar
• Bernardi F, Lanzone A, Cento RM, et al. Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer’s disease and vascular dementia. Eur J Endocrinol 2000;142:466–71
   PubMed Web of Science ®Google Scholar
• Bernardi F, Pluchino N, Begliuomini S, et al. Disadaptive disorders in women: allopregnanolone, a sensitive steroid. Gynecol Endocrinol 2004;19:344–53
   PubMed Web of Science ®Google Scholar
• Barbaccia ML, Roscetti G, Trabucchi M, et al. Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology 1996;63:166–72
   PubMed Web of Science ®Google Scholar
• Barbaccia ML, Serra M, Purdy RH, Biggio G. Stress and neuroactive steroids. Int Rev Neurobiol 2001;46:243–72
   PubMed Web of Science ®Google Scholar
• Guidotti A, Dong E, Matsumoto K, Pinna G, Rasmusson AM, Costa E. The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders. Brain Res Brain Res Rev 2001; 37:110–15
   PubMed Web of Science ®Google Scholar
• Pinna G, Dong E, Matsumoto K, Costa E, Guidotti A. In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci USA 2003;100:2035–40
   PubMed Web of Science ®Google Scholar
• Serra M, Pisu MG, Littera M, et al. Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain. J Neurochem 2000; 75:732–40
   PubMed Web of Science ®Google Scholar
• Semeniuk L, LeMelledo JM, Shangri GS. Neuroactive steroid levels in patients with generalized anxiety disorder. J Neuropsychiatry Clin Neurosci 2001;13:396–8
   PubMed Web of Science ®Google Scholar
• Heydari B, Le Melledo JM. Low pregnanolone sulphate plasma concentrations in patients with generalized social phobia. Psychol Med 2002;32:929–33
   PubMed Web of Science ®Google Scholar
• Brambilla F, Biggio G, Pisu MG, et al. Neurosteroid secretion in panic disorder. Psychiatry Res 2003;118:107–16
   PubMed Web of Science ®Google Scholar
• Khisti RT, Chopde CT, Jain SP. Antidepressant-like effect of the neurosteroid 3a-hydroxy-5a-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 2000;67:137–43
   PubMed Web of Science ®Google Scholar
• Frye CA, Walf AA. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 2002;41:306–15
   PubMed Web of Science ®Google Scholar
• Uzunova V, Sheline Y, Davis JM, et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998;95:3239–44
   PubMed Web of Science ®Google Scholar
• Uzunov DP, Cooper TB, Costa E, Guidotti A. Fluoxetine elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci USA 1996;93: 12599–604
   PubMed Web of Science ®Google Scholar
• Romeo E, Stroehle A, Spalletta G, et al. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 1998;155:910–13
   PubMed Web of Science ®Google Scholar
• Griffin LD, Mellon SH. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA 1999;96:13512–17
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Palumbo MA, de Micheroux AA, et al. Evidence for a role for the neurosteroid allopregnanolone in the modulation of reproductive function in female rats. Eur J Endocrinol 1995;133:375–80
   PubMed Web of Science ®Google Scholar
• Corpechot C, Collins BE, Carey MP, Tsouros A, Robel P, Fry JP. Brain neurosteroids during the mouse oestrous cycle. Brain Res 1997;766:276–80
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Petraglia F, Bernardi F, et al. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab 1998;83:2099–103
   PubMed Web of Science ®Google Scholar
• Monteleone P, Luisi S, Tonetti A, et al. Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 2000;142:269–73
   PubMed Web of Science ®Google Scholar
• Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 1997;90:709–14
   PubMed Web of Science ®Google Scholar
• Bicikova M, Dibbelt L, Hill M, Hampl R, Starka L. Allopregnanolone in women with premenstrual syndrome. Horm Metab Res 1998;30:227–30
   PubMed Web of Science ®Google Scholar
• Bicikova M, Putz Z, Hill M, et al. Serum levels of neurosteroid allopregnanolone in patients with premenstrual syndrome and patients after thyroidectomy. Endocr Regul 1998;32:87–92
   PubMedGoogle Scholar
• Lombardi I, Luisi S, Quirici B, et al. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Gynecol Endocrinol 2004;18:79–87
   PubMed Web of Science ®Google Scholar
• Andréen L, Nyberg S, Turkmen S, van Wingen G, Fernández G, Bäckström T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology 2009;34:1121–32
   PubMed Web of Science ®Google Scholar
• Wang M, Seippel L, Purdy RH, Bäckström T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha- hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 1996;81:1076–82
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Luisi M, Malavasi B, et al. Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur J Endocrinol 2002;146:347–56
   PubMed Web of Science ®Google Scholar
• Monteleone P, Luisi M, Colurcio B, et al. Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa. Psychosom Med 2001;63:62–8
   PubMed Web of Science ®Google Scholar
• Monteleone P, Luisi M, De Filippis G, et al. Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with non-obese healthy controls and non-binge eating obese subjects. Int J Eat Disord 2003;34:432–40
   PubMed Web of Science ®Google Scholar
• Luisi S, Petraglia F, Benedetto C, et al. Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab 2000;85:2429–33
   PubMed Web of Science ®Google Scholar
• Gilbert Evans SE, Ross LE, Sellers EM, Purdy RH, Romach MK. 3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period. Gynecol Endocrinol 2005;21:268–79
   PubMed Web of Science ®Google Scholar
• Maayan R, Fisch B, Galdor M, et al. Influence of 17β estradiol on the synthesis of reduced neurosteroids in the brain (in vivo) and in glioma cells (in vitro): possible relevance to mental disorders in women. Brain Res 2004;1020:167–72
   PubMed Web of Science ®Google Scholar
• Mostallino MC, Sanna E, Concas A, Biggio G, Follesa P. Plasticity and function of extrasynaptic GABA(A) receptors during pregnancy and after delivery. Psychoneuroendocrinology 2009;34:74–83
   Google Scholar
• Hirst JJ, Palliser HK, Yates DM, Yawno T, Walker DW. Neurosteroids in the fetus and neonate: potential protective role in compromised pregnancies. Neurochem Int 2008;52:602–10
   PubMed Web of Science ®Google Scholar
• Concas A, Mostallino MC, Porcu P, et al. Role of brain allopregnanolone in the plasticity of g-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci USA 1998;95:13284–89
   PubMed Web of Science ®Google Scholar
• Follesa P, Floris S, Tuligi G, Mostallino MC, Concas A, Biggio G. Molecular and functional adaptation of the GABAA receptor complex during pregnancy and after delivery in the rat brain. Eur J Neurosci 1998;10:2905–12
   PubMed Web of Science ®Google Scholar
• Sanna E, Mostallino MC, Murru L, et al. Changes in expression and function of extrasynaptic GABAA receptors in the rat hippocampus during pregnancy and after delivery. J Neurosci 2009;29:1755–65
   PubMed Web of Science ®Google Scholar
• Zuluaga MJ, Agrati D, Pereira M, Uriarte N, Fernandez-Guasti A, Ferreira A. Experimental anxiety in the black and white model in cycling, pregnant and lactating rats. Physiol Behav 2005;84:279–86
   PubMed Web of Science ®Google Scholar
• de Brito Faturi C, Teixeira-Silva F, Leite JR. The anxiolytic effect of pregnancy in rats is reversed by finasteride. Pharmacol Biochem Behav 2006;85:569–74
   PubMed Web of Science ®Google Scholar
• Skouteris H, Wertheim EH, Rallis S, Milgrom J, Paxton SJ. Depression and anxiety through pregnancy and the early postpartum: an examination of prospective relationships. J Affect Disord 2009;113:303–8
   PubMed Web of Science ®Google Scholar
• Smith SS, Gong QH, Hsu FC, Markowitz RS, ffrench-Mullen JM, Li X. GABAA receptor a4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998;392:926–30
   PubMed Web of Science ®Google Scholar
• Smith SS, Gong QH, Li X, Moran MH, Bitran D, Frye CA, Hsu FC. Withdrawal from 3a-OH-5a-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor a4 subunit in association with increased anxiety. J Neurosci 1998; 18:5275–84
   PubMed Web of Science ®Google Scholar
• Smith SS, Ruderman Y, Frye C, Homanics G, Yuan M. Steroid withdrawal in the mouse results in anxiogenic effects of 3a, 5b-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology 2006;186:323–33
   PubMed Web of Science ®Google Scholar
• Pawluski JL, Vanderbyl BL, Ragan K, Galea LA. First reproductive experience persistently affects spatial reference and working memory in the mother and these effects are not due to pregnancy or ‘mothering’ alone. Behav Brain Res 2006;175: 157–65
   PubMed Web of Science ®Google Scholar
• Walf AA, Frye CA. Estradiol decreases anxiety behavior and enhances inhibitory avoidance and gestational stress produces opposite effects. Stress 2007;10:251–60
   PubMed Web of Science ®Google Scholar
• Kinsley CH, Lambert KG. Reproduction-induced neuroplasticity: natural behavioural and neuronal alterations associated with the production and care of offspring. J Neuroendocrinol 2008;4:515–25
   Google Scholar
• Paris JJ, Frye CA. Estrous cycle, pregnancy, and parity enhance performance of rats in object recognition or object placement tasks. Reproduction 2008;136:105–15
   PubMed Web of Science ®Google Scholar
• Leuner B, Mirescu C, Noiman L, Gould E. Maternal experience inhibits the production of immature neurons in the hippocampus during the postpartum period through elevations in adrenal steroids. Hippocampus 2007;17:434–42
   PubMed Web of Science ®Google Scholar
• Pawluski JL, Galea LA. Reproductive experience alters hippocampal neurogenesis during the postpartum period in the dam. Neuroscience 2007;149:53–67
   PubMed Web of Science ®Google Scholar
• Frye CA. Neurosteroid s'effects and mechanisms for social, cognitive, emotional, and physical functions. Psychoneuroendocrinology 2009;34:143–61
   Google Scholar
• Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 2003;44:234–46
   PubMed Web of Science ®Google Scholar
• Smith R, Thomson M. Neuroendocrinology of the hypothalamo-pituitary-adrenal axis in pregnancy and the puerperium. Clin Endocrinol Metab 1991;5:167–86
   Google Scholar
• Tulchinsky D, Hobel CJ, Yeager EM. Plasma estrone, estradiol, estriol, progesterone and 17-hydroxyprogesterone in human pregnancy. Am J Obstet Gynecol 1972;112:1095–100
   PubMed Web of Science ®Google Scholar
• Heidrich A, Schleyer M, Spingler H, et al. Postpartum blues: relationship between not protein bound steroid hormones in plasma and postpartum mood changes. J Affective Disord 1994;30:93–8
   PubMed Web of Science ®Google Scholar
• Gordon JH, Perry KO. Pre- and postsynaptic neurochemical alterations following estrogen-induced striatal dopamine hypo- and hypersensitivity. Brain Res Bull 1983;10:425–8
   PubMed Web of Science ®Google Scholar
• Wieck A, Kumar R, Hirst AD, Marks MN, Campbell IC, Checkley SA. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. Br Med J 1991;303:613–16
   PubMed Web of Science ®Google Scholar
• Bosse R, Rivest R, Dipaolo T. Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. Brain Res Mol Brain Res 1997;46:343–6
   PubMedGoogle Scholar
• Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347:930–3
   PubMed Web of Science ®Google Scholar
• Paul SM, Purdy RH. Neuroactive steroids. FASEB J 1992;6: 2311–22
   PubMed Web of Science ®Google Scholar
• Costa A-MN, Spence KT, Smith SS, ffRench-Mullen JMH. Withdrawal from the endogenous steroid progesterone results in GABAA currents insensitive to benzodiazepine modulation in rat CA1 hippocampus. J Neurophysiol 1995; 4:464–9
   Google Scholar
• Nicosia A, Giardina L, Di Leo F, et al. Long-lasting behavioral changes induced by pre- or neonatal exposure to diazepam in rats. Eur J Pharmacol 2003;469:103–9
   PubMed Web of Science ®Google Scholar
• Nappi RE, Petraglia F, Luisi S, Polatti F, Farina C, Genazzani AR. Serum allopregnanolone in women with postpartum “blues”. Obstet Gynecol 2001;97:77–80
   PubMed Web of Science ®Google Scholar
• Majewska MD, Ford-Rice R, Falkay G. Pregnancy-induced alterations of GABAA receptor sensitivity in maternal brain: an antecedent of post-partum ‘blues’? Brain Res 1989;482:397–401
   PubMed Web of Science ®Google Scholar
• Bitran D, Shiekh M, MacLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroids anolone at brain GABAa receptors. J Neuroendocrinol 1995;7:171–7
   PubMed Web of Science ®Google Scholar
• Parker CR, Favor JK, Carden LG, Brown CH. Effects of intrapartum stress on fetal adrenal function. Am J Obstet Gynecol 1993;169:1407–11
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Gambacciani M, Simoncini T, Schneider HPG. HRT in climacteric and aging brain. Climacteric 2003;6: 188–203
   PubMed Web of Science ®Google Scholar
• Naylor JC, Kilts JD, Hulette CM, et al. Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects. Biochim Biophys Acta 2010;1801:951–9
   PubMed Web of Science ®Google Scholar
• Wang JM, Singh C, Liu L, et al. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2010;107:6498–503
   PubMed Web of Science ®Google Scholar
• Schumacher M, Hussain R, Gago N, Oudinet JP, Mattern C, Ghoumari AM. Progesterone synthesis in the nervous system: implications for myelination and myelin repair. Front Neurosci 2012;6:10
   PubMed Web of Science ®Google Scholar
• Brinton RD. Neurosteroids as regenerative agents in the brain: therapeutic implications. Nat Rev Endocrinol 2013;9:241–50
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Bernardi F, Pluchino N, et al. Endocrinology of menopausal transition and its brain implications. CNS Spectr 2005;10:449–57
   PubMed Web of Science ®Google Scholar
• McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: Implications for cognition and aging. Neurology 1997;48:8–15
   PubMed Web of Science ®Google Scholar
• Pluchino N, Bucci F, Cela V, Cubeddu A, Genazzani AR. Menopause and mental well-being: timing of symptoms and timing of hormone treatment. Womens Health (Lond Engl) 2011;7:71–80
   PubMedGoogle Scholar
• North American Menopause Society. Menopause Guidebook, 6th edn. Cleveland, OH: North American Menopause Society, 2006
   Google Scholar
• Bernardi F, Pieri M, Stomati M, et al. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women. Gynecol Endocrinol 2003;17:65–77
   PubMed Web of Science ®Google Scholar
• Morrison JH, Brinton RD, Schmidt PJ, Gore AC. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci 2006;26:10332–48
   PubMed Web of Science ®Google Scholar
• Siegfried T. Neuroscience: it’s all in the timing. Nature 2007;445:359–61
   PubMed Web of Science ®Google Scholar
• Pluchino N, Cubeddu A, Giannini A, et al. Progestogens and brain: an update. Maturitas 2009;62:349–55
   PubMed Web of Science ®Google Scholar
• Stanczyk FZ. All progestins are not created equal. Steroids 2003;68:879–90
   PubMed Web of Science ®Google Scholar
• Nilsen J, Brinton RD. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci 2003;100:10506–11
   PubMed Web of Science ®Google Scholar
• Morali G, Lemus AE, Munguia R, Garcia GA, Grillasca I, Perez-Palacios G. Hormone-like behavioral effects of levonorgestrel and its metabolites in the male rat. Pharmacol Biochem Behav 2002;73:951–61
   PubMed Web of Science ®Google Scholar
• Garcia-Becerra R, Borja-Cacho E, Cooney AJ, et al. The intrinsic transcriptional estrogenic activity of a non-phenolic derivative of levonorgestrel is mediated via the estrogen receptor-alpha. J Steroid Biochem Mol Biol 2002;82:333–41
   PubMed Web of Science ®Google Scholar
• Winneker RC, Bitran D, Zhang Z. The preclinical biology of a new potent and selective progestin: trimegestone. Steroids 2003;68:915–20
   PubMed Web of Science ®Google Scholar
• Pluchino N, Genazzani AD, Bernardi F, et al. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecol Endocrinol 2005;20:144–9
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update 2006;12:169–78
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Petraglia F, Bergamaschi M, Genazzani AD, Facchinetti F, Volpe A. Progesterone and progestins modulate beta-endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats. Gynecol Endocrinol 1987;1:61–9
   PubMedGoogle Scholar
• Genazzani AR, Bernardi F, Pluchino N, et al. Effect of tibolone administration on central and peripheral levels of allopregnanolone and beta-endorphin in female rats. Menopause 2006;13:57–64
   PubMed Web of Science ®Google Scholar
• Bernardi F, Pluchino N, Pieri M, et al. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels. Neuroendocrinology 2006;83:348–59
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Pluchino N, Begliuomini S, et al. Drospirenone increases central and peripheral beta-endorphin in ovariectomized female rats. Menopause 2007;14:63–73
   PubMed Web of Science ®Google Scholar
• Stein DG. Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update. Neuroscience 2011;191:101–6
   PubMed Web of Science ®Google Scholar
• Stein DG. A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury? Horm Behav 2013;63:291–300
   PubMed Web of Science ®Google Scholar
• Wright DW, Kellermann AL, Hertzberg VS, et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 2007;49:391–402
   PubMed Web of Science ®Google Scholar
• Harper AJ, Buster JE, Casson PR. Changes in adrenocortical function with aging and therapeutic implications. Semin Reprod Endocrinol 1999;17:327–38
   PubMedGoogle Scholar
• Davis SR, Panjari M, Stanczyk FZ. DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011;96:1642–3
   PubMed Web of Science ®Google Scholar
• Labrie F, Luu-The V, Bélanger A, et al. Is dehydroepiandrosterone a hormone? J Endocrinol 2005;187:169–96
   PubMed Web of Science ®Google Scholar
• Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91–6
   PubMed Web of Science ®Google Scholar
• Davis SR, Shah SM, McKenzie DP, Kulkarni J, Davison SL, Bell RJ. Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab 2008;93:801–8
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Pluchino N, Begliuomini S, et al. Long-term low-dose oral administration of dehydroepiandrosterone modulates response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol 2006;22: 627–35
   PubMed Web of Science ®Google Scholar
• Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 2009;30:65–91
   PubMed Web of Science ®Google Scholar
• Pluchino N, Ninni F, Stomati M, et al. One year therapy with 10 mg/die DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu. Maturitas 2008;59:296–303
   Google Scholar
• Genazzani AR, Pluchino N. DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence. Climacteric 2010;13:314–16
   PubMed Web of Science ®Google Scholar